AC-1204

DRUG3 trials

Sponsors

Cerecin

Conditions

Alzheimer's DiseaseHealthy

Phase 1

Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body Production

CompletedNCT02747602

Start: 2016-04-30End: 2016-10-31Updated: 2016-10-28

Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production

CompletedNCT02833012

Start: 2016-07-31End: 2016-12-31Updated: 2017-04-11

Phase 2

AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext

CompletedNCT01741194

CerecinAlzheimer's Disease

Start: 2013-03-31End: 2017-04-14Updated: 2021-08-02

Related Papers

A Placebo-Controlled, Parallel-Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer's Disease.

2020-01-0133 citations

P4‐211: INVESTIGATIONAL NEW ALZHEIMER'S DRUG TRICAPRILIN: POSSIBLE EFFECTS OF APOEε4 NON‐CARRIER SELECTION AND SITE EFFECTS ON STUDY OUTCOMES IN A PHASE 2/3 STUDY IN MILD‐TO‐MODERATE ALZHEIMER'S DISEASE PATIENTS

Alzheimer s & Dementia2018-07-011 citations